CN Stock MarketDetailed Quotes

301370 GKHT Medical Technology

Watchlist
  • 9.87
  • +0.31+3.24%
Market Closed Sep 26 15:00 CST
4.64BMarket Cap30.75P/E (TTM)

GKHT Medical Technology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
Total operating revenue
-5.59%3.66B
-3.00%1.71B
17.66%7.48B
17.74%5.76B
28.41%3.88B
14.98%1.77B
8.76%6.36B
-15.92%4.89B
-21.33%3.02B
-12.81%1.54B
Operating revenue
-5.59%3.66B
-3.00%1.71B
17.66%7.48B
17.74%5.76B
28.41%3.88B
14.98%1.77B
8.76%6.36B
-15.92%4.89B
-21.33%3.02B
-12.81%1.54B
Other operating revenue
12.99%21.91M
----
12.92%36.81M
----
58.55%19.39M
----
-0.91%32.6M
----
-7.57%12.23M
--7.63M
Total operating cost
-4.35%3.58B
-1.49%1.68B
18.31%7.24B
18.28%5.57B
28.59%3.74B
15.48%1.71B
9.78%6.12B
4.71B
-21.81%2.91B
1.48B
Operating cost
-3.50%3.28B
-1.36%1.53B
19.65%6.6B
18.80%5.07B
29.74%3.4B
16.13%1.56B
9.93%5.52B
--4.27B
-23.97%2.62B
--1.34B
Operating tax surcharges
12.52%10.05M
-7.72%4.44M
-1.10%19.25M
17.14%12.64M
19.06%8.93M
26.09%4.81M
1.39%19.47M
-19.69%10.79M
-10.01%7.5M
--3.82M
Operating expense
-12.45%165.93M
1.05%85.26M
14.88%376.17M
19.83%282.77M
29.74%189.53M
22.83%84.37M
17.84%327.46M
--235.98M
10.12%146.08M
--68.69M
Administration expense
-0.76%76.52M
19.31%36.3M
17.65%141.78M
30.90%121.91M
25.83%77.11M
0.64%30.42M
6.72%120.51M
--93.13M
10.53%61.28M
--30.23M
Financial expense
-35.35%36.07M
-34.40%19.53M
-28.36%87.15M
-19.42%75.63M
-14.20%55.79M
-12.26%29.77M
-9.48%121.65M
--93.85M
-5.02%65.02M
--33.93M
-Interest expense (Financial expense)
-36.67%33.73M
-36.30%17.89M
-26.10%88.18M
-18.19%73.43M
-14.48%53.26M
-12.57%28.09M
-7.48%119.32M
--89.76M
-1.80%62.28M
--32.13M
-Interest Income (Financial expense)
-13.96%-2.82M
10.37%-1.28M
-77.01%-5.62M
-102.19%-4.3M
-91.17%-2.48M
-135.79%-1.43M
-11.32%-3.18M
---2.13M
19.66%-1.3M
---605.06K
Research and development
-11.93%5M
-17.72%2.46M
4.03%12.9M
-1.66%8.65M
1.33%5.68M
10.12%2.99M
17.57%12.4M
11.53%8.8M
6.55%5.6M
--2.72M
Credit Impairment Loss
74.79%-5.84M
116.18%1.61M
126.01%10.51M
-4.48%-31.16M
-4.53%-23.16M
-2.31%-9.95M
-69.04%-40.41M
-48.62%-29.83M
-58.22%-22.15M
---9.73M
Asset Impairment Loss
58.98%-4.21M
3.39%-6.82M
-54.93%-17.33M
-29.43%-10.64M
-162.85%-10.27M
-69.97%-7.06M
37.02%-11.19M
---8.22M
76.90%-3.91M
---4.15M
Other net revenue
71.63%-9.1M
69.96%-4.9M
93.69%-2.65M
-13.50%-35.14M
-35.58%-32.07M
-23.35%-16.31M
-47.58%-41.93M
-54.26%-30.96M
11.33%-23.66M
-13.22M
Invest income
--18.15K
----
---4.99M
----
----
----
--0
----
----
----
Asset deal income
-5,860.90%-149.56K
-13,315.40%-164.18K
-184.06%-182.79K
-550.09%-127.9K
-90.80%2.6K
38.84%-1.22K
853.54%217.46K
--28.42K
--28.22K
---2K
Other revenue
-20.07%1.08M
-32.79%472.77K
-1.02%9.35M
-3.82%6.79M
-43.01%1.36M
6.36%703.44K
-28.91%9.44M
--7.06M
-43.94%2.38M
--661.4K
Operating profit
-29.56%74.2M
-37.06%27.42M
21.33%239.07M
2.03%157.4M
20.66%105.34M
-3.80%43.56M
-19.02%197.04M
6.10%154.28M
-4.70%87.3M
1.02%45.29M
Add:Non operating Income
706.75%34.3K
1,656.19%15.81K
-98.49%5K
-98.48%4.78K
-98.57%4.25K
354.55%900
844.07%331.43K
16,478.02%314.98K
26,891.51%296.88K
--198
Less:Non operating expense
-23.68%853.94K
-76.06%248.37K
91.13%2.99M
82.26%1.89M
223.62%1.12M
538.39%1.04M
3.05%1.57M
2.32%1.04M
-31.57%345.75K
--162.54K
Total profit
-29.59%73.38M
-36.08%27.18M
20.57%236.08M
1.28%155.51M
19.45%104.23M
-5.76%42.53M
-19.03%195.81M
6.35%153.55M
-4.23%87.25M
1.44%45.12M
Less:Income tax cost
-75.25%7.94M
-65.84%4.7M
21.70%65.37M
31.34%54.33M
49.67%32.09M
18.89%13.75M
-13.36%53.71M
--41.37M
-9.98%21.44M
--11.57M
Net profit
-9.28%65.44M
-21.85%22.49M
20.14%170.71M
-9.81%101.18M
9.61%72.13M
-14.25%28.77M
-20.99%142.1M
6.42%112.19M
-2.19%65.81M
-4.69%33.56M
Net profit from continuing operation
-9.28%65.44M
-21.85%22.49M
20.14%170.71M
-9.81%101.18M
9.61%72.13M
-14.25%28.77M
-20.99%142.1M
--112.19M
-2.19%65.81M
--33.56M
Less:Minority Profit
-59.35%2.52M
-310.16%-5.12M
-2.06%16.83M
-42.93%10.17M
-48.44%6.2M
-70.41%2.44M
-39.97%17.19M
--17.83M
8.08%12.03M
--8.23M
Net profit of parent company owners
-4.56%62.92M
4.82%27.61M
23.19%153.88M
-3.55%91.01M
22.59%65.93M
4.01%26.34M
-17.39%124.91M
3.36%94.36M
-4.23%53.78M
-1.37%25.32M
Earning per share
Basic earning per share
-18.75%0.13
-14.29%0.06
16.13%0.36
-8.33%0.22
23.08%0.16
16.67%0.07
-18.42%0.31
--0.24
-7.14%0.13
--0.06
Diluted earning per share
-18.75%0.13
-14.29%0.06
16.13%0.36
-8.33%0.22
23.08%0.16
--0.07
--0.31
--0.24
--0.13
----
Other composite income
Total composite income
-9.28%65.44M
-21.85%22.49M
20.14%170.71M
-9.81%101.18M
9.61%72.13M
-14.25%28.77M
-20.99%142.1M
112.19M
-2.19%65.81M
33.56M
Total composite income of parent company owners
-4.56%62.92M
4.82%27.61M
23.19%153.88M
-3.55%91.01M
22.59%65.93M
4.01%26.34M
-17.39%124.91M
--94.36M
-4.23%53.78M
--25.32M
Total composite income of minority owners
-59.35%2.52M
-310.16%-5.12M
-2.06%16.83M
-42.93%10.17M
-48.44%6.2M
-70.41%2.44M
-39.97%17.19M
--17.83M
8.08%12.03M
--8.23M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Auditor
--
--
Grant Tung Certified Public Accountants (Special General Partnership)
--
--
--
Grant Tung Certified Public Accountants (Special General Partnership)
--
--
--
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022
Total operating revenue -5.59%3.66B-3.00%1.71B17.66%7.48B17.74%5.76B28.41%3.88B14.98%1.77B8.76%6.36B-15.92%4.89B-21.33%3.02B-12.81%1.54B
Operating revenue -5.59%3.66B-3.00%1.71B17.66%7.48B17.74%5.76B28.41%3.88B14.98%1.77B8.76%6.36B-15.92%4.89B-21.33%3.02B-12.81%1.54B
Other operating revenue 12.99%21.91M----12.92%36.81M----58.55%19.39M-----0.91%32.6M-----7.57%12.23M--7.63M
Total operating cost -4.35%3.58B-1.49%1.68B18.31%7.24B18.28%5.57B28.59%3.74B15.48%1.71B9.78%6.12B4.71B-21.81%2.91B1.48B
Operating cost -3.50%3.28B-1.36%1.53B19.65%6.6B18.80%5.07B29.74%3.4B16.13%1.56B9.93%5.52B--4.27B-23.97%2.62B--1.34B
Operating tax surcharges 12.52%10.05M-7.72%4.44M-1.10%19.25M17.14%12.64M19.06%8.93M26.09%4.81M1.39%19.47M-19.69%10.79M-10.01%7.5M--3.82M
Operating expense -12.45%165.93M1.05%85.26M14.88%376.17M19.83%282.77M29.74%189.53M22.83%84.37M17.84%327.46M--235.98M10.12%146.08M--68.69M
Administration expense -0.76%76.52M19.31%36.3M17.65%141.78M30.90%121.91M25.83%77.11M0.64%30.42M6.72%120.51M--93.13M10.53%61.28M--30.23M
Financial expense -35.35%36.07M-34.40%19.53M-28.36%87.15M-19.42%75.63M-14.20%55.79M-12.26%29.77M-9.48%121.65M--93.85M-5.02%65.02M--33.93M
-Interest expense (Financial expense) -36.67%33.73M-36.30%17.89M-26.10%88.18M-18.19%73.43M-14.48%53.26M-12.57%28.09M-7.48%119.32M--89.76M-1.80%62.28M--32.13M
-Interest Income (Financial expense) -13.96%-2.82M10.37%-1.28M-77.01%-5.62M-102.19%-4.3M-91.17%-2.48M-135.79%-1.43M-11.32%-3.18M---2.13M19.66%-1.3M---605.06K
Research and development -11.93%5M-17.72%2.46M4.03%12.9M-1.66%8.65M1.33%5.68M10.12%2.99M17.57%12.4M11.53%8.8M6.55%5.6M--2.72M
Credit Impairment Loss 74.79%-5.84M116.18%1.61M126.01%10.51M-4.48%-31.16M-4.53%-23.16M-2.31%-9.95M-69.04%-40.41M-48.62%-29.83M-58.22%-22.15M---9.73M
Asset Impairment Loss 58.98%-4.21M3.39%-6.82M-54.93%-17.33M-29.43%-10.64M-162.85%-10.27M-69.97%-7.06M37.02%-11.19M---8.22M76.90%-3.91M---4.15M
Other net revenue 71.63%-9.1M69.96%-4.9M93.69%-2.65M-13.50%-35.14M-35.58%-32.07M-23.35%-16.31M-47.58%-41.93M-54.26%-30.96M11.33%-23.66M-13.22M
Invest income --18.15K-------4.99M--------------0------------
Asset deal income -5,860.90%-149.56K-13,315.40%-164.18K-184.06%-182.79K-550.09%-127.9K-90.80%2.6K38.84%-1.22K853.54%217.46K--28.42K--28.22K---2K
Other revenue -20.07%1.08M-32.79%472.77K-1.02%9.35M-3.82%6.79M-43.01%1.36M6.36%703.44K-28.91%9.44M--7.06M-43.94%2.38M--661.4K
Operating profit -29.56%74.2M-37.06%27.42M21.33%239.07M2.03%157.4M20.66%105.34M-3.80%43.56M-19.02%197.04M6.10%154.28M-4.70%87.3M1.02%45.29M
Add:Non operating Income 706.75%34.3K1,656.19%15.81K-98.49%5K-98.48%4.78K-98.57%4.25K354.55%900844.07%331.43K16,478.02%314.98K26,891.51%296.88K--198
Less:Non operating expense -23.68%853.94K-76.06%248.37K91.13%2.99M82.26%1.89M223.62%1.12M538.39%1.04M3.05%1.57M2.32%1.04M-31.57%345.75K--162.54K
Total profit -29.59%73.38M-36.08%27.18M20.57%236.08M1.28%155.51M19.45%104.23M-5.76%42.53M-19.03%195.81M6.35%153.55M-4.23%87.25M1.44%45.12M
Less:Income tax cost -75.25%7.94M-65.84%4.7M21.70%65.37M31.34%54.33M49.67%32.09M18.89%13.75M-13.36%53.71M--41.37M-9.98%21.44M--11.57M
Net profit -9.28%65.44M-21.85%22.49M20.14%170.71M-9.81%101.18M9.61%72.13M-14.25%28.77M-20.99%142.1M6.42%112.19M-2.19%65.81M-4.69%33.56M
Net profit from continuing operation -9.28%65.44M-21.85%22.49M20.14%170.71M-9.81%101.18M9.61%72.13M-14.25%28.77M-20.99%142.1M--112.19M-2.19%65.81M--33.56M
Less:Minority Profit -59.35%2.52M-310.16%-5.12M-2.06%16.83M-42.93%10.17M-48.44%6.2M-70.41%2.44M-39.97%17.19M--17.83M8.08%12.03M--8.23M
Net profit of parent company owners -4.56%62.92M4.82%27.61M23.19%153.88M-3.55%91.01M22.59%65.93M4.01%26.34M-17.39%124.91M3.36%94.36M-4.23%53.78M-1.37%25.32M
Earning per share
Basic earning per share -18.75%0.13-14.29%0.0616.13%0.36-8.33%0.2223.08%0.1616.67%0.07-18.42%0.31--0.24-7.14%0.13--0.06
Diluted earning per share -18.75%0.13-14.29%0.0616.13%0.36-8.33%0.2223.08%0.16--0.07--0.31--0.24--0.13----
Other composite income
Total composite income -9.28%65.44M-21.85%22.49M20.14%170.71M-9.81%101.18M9.61%72.13M-14.25%28.77M-20.99%142.1M112.19M-2.19%65.81M33.56M
Total composite income of parent company owners -4.56%62.92M4.82%27.61M23.19%153.88M-3.55%91.01M22.59%65.93M4.01%26.34M-17.39%124.91M--94.36M-4.23%53.78M--25.32M
Total composite income of minority owners -59.35%2.52M-310.16%-5.12M-2.06%16.83M-42.93%10.17M-48.44%6.2M-70.41%2.44M-39.97%17.19M--17.83M8.08%12.03M--8.23M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----Unqualified opinion------Unqualified opinion------
Auditor ----Grant Tung Certified Public Accountants (Special General Partnership)------Grant Tung Certified Public Accountants (Special General Partnership)------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data